Home » Newsletters » BioWorld Science

BioWorld Science

July 8, 2004

View Archived Issues

A sustained-release formulation of lanreotide shows efficacy in acromegaly

Good safety and pharmacokinetic profile of intranasal PYY3-36 in healthy volunteers

Oralin reported to improve mealtime glycemic control in type 2 diabetes

Comparison of sleep induction with melatonin, zaleplon, zopiclone and temazepam

Elan submits Prialt NDA amendment

Remoxy results demonstrate Oradur utility

ZymoGenetics licenses to Novo Nordisk rights to IL-28A, IL-29 and IL-31

FDA approval of NeutroSpec for diagnosis of appendicitis

ViraGen licenses Oxford BioMedica's LentiVector gene delivery technology

AltaRex signs distribution agreement with Dompe

sBLA filed for Bexxar

NeoRx files IND for phase II study of STR in metastatic breast cancer

IDEA receives milestone for progression of targeted pain therapeutic

Second clinical trial evaluates trans-NV-04

Pharming and Esteve reach agreement on rhC1INH

NexMed and Schering AG sign Alprox-TD agreement

U.S. phase II study of FM-VP4 planned for next year

Pharmion launches Vidaza

Forest and PAION enter agreement for desmoteplase in U.S. and Canada

Guidant and Miravant to collaborate on cardiovascular PDT development

Dosing commences in phase III trial of TransMID for glioblastoma multiforme

Positive opinion handed down in Europe for Protelos

Wilzin recommended for approval in Europe for Wilson's disease

Novel DPP-IV inhibitors claimed by Boehringer Ingelheim

FKBP12 ligands for neurodegenerative diseases in early development at Taisho

Boehringer Ingelheim patent describes series of cytokine inhibitors

Modulators of tyrosine kinase-mediated signal transduction disclosed in patent

PDE4 inhibitors prepared and tested at elbion

Gastric and intestinal protectants claimed in Altana patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...